Otonomy, Inc.
NEUROTROPHIN MUTANTS FOR TREATING HEARING LOSS AND OTHER OTIC DISORDERS
Last updated:
Abstract:
Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with a non-natural neurotrophic agent compositions and formulations administered to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Status:
Application
Type:
Utility
Filling date:
26 Jan 2018
Issue date:
12 Dec 2019